Indie developer Critical Wit has announced AI Confidential, a new adventure game where you “mend everything from broken parts to broken hearts.”
AI Confidential is in development for Windows PC (via Steam), though a release date wasn’t confirmed.
Here’s a rundown on the game, plus its reveal trailer:
Artificial Intelligence, Real Problems: You are Makenzy Turner, an affable RoboTechnician employed by AI megacorp, Indelligent Solutions. With your trusty assistant ARI, use high-tech tools and old-fashioned empathy to mend everything from broken parts to broken hearts.
Just (Re)Act Naturally! AIC’s emoji interactions place the emphasis on disposition and emotional intent. Unlike conventional (text-driven) dialog systems, react to what’s been said, using emoji to influence the tenor and tone of conversations.
Robotic Rehabilitation in Four ‘Simple’ Steps:
- Step 1: The Owner, the Bot, & the Boss (Case Briefing) – Meet your purpose-built patient to get their perspective. Get marching orders from HQ, and a hot take from the broken bot’s owner.
- Step 2: Solarpunk Sleuthing (Explore & Investigate) – Uncover possible causes of malfunctions and misbehavior. Chat with other AI in the area for clues and leads.
- Step 3: Subjective Solutions (Diagnosis & Treatment) – Determine a diagnosis, and evaluate a possible treatment… or three. Execute the “best” option, or consider doing something… unsanctioned.
- Step 4: Rocks and Hard Places (Metanarrative Mindfulness) – What’s best for the patient isn’t always what the customer or your company wants. Your decisions dictate the fates of your patients, relationships… and career.
Key Features:
- A unique, playful and intuitive emoji-driven dialog system.
- An unforgettable cast of purpose-built patients to meet and help.
- An array of environments in a solarpunk future to explore.
- Classic adventure game inventory puzzles… minus the moon logic.
- From hardware repair, to virus removal, assist your patients with invasive aplomb.
- Decommission ‘lost causes,’ and return their cores to R&D.